Patents for A61P 17 - Drugs for dermatological disorders (106,455)
02/2009
02/18/2009EP2025344A1 Melanoma Therapy
02/18/2009EP2025341A1 Ointment for combating and treating skin diseases, and process for preparing said ointment
02/18/2009EP2024368A2 6,7,8,9-tetrahydro-5h-pyrimido[4,5-d]azepin-4-yl]-amine derivatives as modulators of trpv1 for the treatment of pain
02/18/2009EP2023955A2 Administration of anti-cd3 antibodies in the treatment of autoimmune diseases
02/18/2009EP2023910A1 Ah receptor antagonists
02/18/2009EP1727801B1 Piperazines useful for treating pain
02/18/2009EP1638582B1 Use of hyaluronic acid for preparing compositions for treating recurrent oral cavity aphthas
02/18/2009EP1614684B1 Diamine derivative, production process, and antioxidizing drug
02/18/2009EP1576368B1 Methods and compositions for enhancing fibrocyte formation
02/18/2009EP1458757B1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor
02/18/2009EP1444210B1 Qunazoline derivatives as antitumor agents
02/18/2009EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases
02/18/2009EP1366063B1 Inhibitors of lyn-associated signal transduction (last) and the use thereof in the treatment of prostate cancer
02/18/2009EP1360178B1 Novel heterocyclic analogs of diphenylethylene compounds
02/18/2009EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents
02/18/2009EP0812184B2 Nitric oxide synthase inhibitors for topical use
02/18/2009CN201194936Y Socks card for preventing and controlling calcaneal xerochasy
02/18/2009CN101370804A Aminophenyl derivatives as novel inhibitors of histone deacetylase
02/18/2009CN101370489A Use of alkanedicarboxylic acids and retinoids for treatment of rosacea and other inflammatory skin diseases
02/18/2009CN101367877A Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms, pharmaceutical compositions
02/18/2009CN101366940A Prescription for removing chloasma
02/18/2009CN101366931A Externally used medicine for eczema
02/18/2009CN101366930A Traditional Chinese medicine for treating neurodermatitis
02/18/2009CN101366924A Chinese medicine for wound
02/18/2009CN101366922A Proprietary Chinese medicine for treating empyrosis
02/18/2009CN101366911A Traditional Chinese medicine for treating alopecia
02/18/2009CN101366899A Chinese medicinal composition for treating eczema
02/18/2009CN101366894A Erysipelas treating prescription
02/18/2009CN101366893A Medicament for treating scabies
02/18/2009CN101366886A Detumescent medicament
02/18/2009CN101366885A Centipede ointment for treating skin cancer
02/18/2009CN101366879A Medicine for treating psoriasis
02/18/2009CN101366861A Capsule for treating prematurely grey hair
02/18/2009CN101366860A Jiaomei oral liquid for benefiting sleep and removing speckle
02/18/2009CN101366859A Medicament for treating tinea manus and pedis, fester foot
02/18/2009CN101366856A Quality control method for Chinese medicinal composition for treating ichthyosis
02/18/2009CN101366855A Traditional Chinese medicine lotion for treating anus and intestine eczema
02/18/2009CN101366854A Medicament for treating eczema
02/18/2009CN101366853A Chinese medicinal composition for treating athlete's foot
02/18/2009CN101366851A Externally used traditional Chinese medicine liniment for treating wart
02/18/2009CN101366848A Pill for removing fat and generating hair
02/18/2009CN101366846A Medicament for burn, scald and ulcer
02/18/2009CN101366825A Medicament for treating ringworm of the nails
02/18/2009CN101366735A Externally used compound wound plaster prescription
02/18/2009CN101366728A Compositions for preventing or treating skin defects and methods of use thereof
02/18/2009CN101366726A Medicament composition for treating skin diseases
02/18/2009CN101366717A Medicament formulation for treating condyloma acuminata
02/18/2009CN101366691A Application of glossy ganoderma spore oil in preparing cosmetics or medicament for whitening and removing speckle
02/18/2009CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament
02/18/2009CN100462352C Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
02/18/2009CN100462351C Amino acids with affinity for the alpha-2-delta-protein
02/18/2009CN100462079C Externally applied sulfamylonum formulation and its preparation method
02/18/2009CN100462070C Retinoic acid release control nanomicrosphere and its preparation method
02/17/2009US7491825 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD)
02/17/2009US7491741 Diaminopropionic acid derivatives
02/17/2009US7491740 Isoxazoline compounds having MIF antagonist activity
02/17/2009US7491734 psychotic and intellectual impairment disorders; Alzheimer's disease, cognitive or attention disorders, antidepressant, anxiolytic agent; ,smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's syndrome, and Parkinson's disease
02/17/2009US7491730 Compositions useful as inhibitors of GSK-3
02/17/2009US7491722 Pyridazin-3(2H)-one derivatives
02/17/2009US7491677 Composite sample on support; concentration gradients
02/17/2009US7491516 Dual specificity antibodies and methods of making and using
02/17/2009US7491410 Food grade transglutaminase inhibitor and uses thereof
02/17/2009US7491389 Bone marrow; controlling cell differentiation
02/17/2009CA2400217C Pteridine compounds for the treatment of psoriasis
02/17/2009CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
02/12/2009WO2009020650A2 Materials and methods for treating and managing wounds and the effects of trauma
02/12/2009WO2009020534A2 Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines
02/12/2009WO2009020192A1 Composition for oral intake for preventing ultraviolet damage
02/12/2009WO2009020104A1 Gel-like composition for external application comprising adenine compound
02/12/2009WO2009019473A1 Treatments for inflammatory arthritis
02/12/2009WO2009019385A1 Use of eflucimibe for the production of a medicament for the prevention or treatment of a disease caused by sebaceous gland dysfunction in humans or animals
02/12/2009WO2009002811A3 Therapeutic platelet compositions and methods
02/12/2009WO2009001260A3 Cosmetic use of apolipoprotein d type proteins
02/12/2009WO2008152260A3 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics
02/12/2009WO2008149022A3 Use of gem-difluorinated c-glycopeptides for promoting the pigmentation of keratinic materials
02/12/2009US20090042958 Composition and method for treating immune-mediated skin disorders
02/12/2009US20090042945 Benzo[d]isoxazol-3-yl-amine Compounds and Their Use as Vanilloid Receptor Ligands
02/12/2009US20090042909 Method of treating dermatological disorders
02/12/2009US20090042901 Agent for prevention/therapy of disease caused by keratinocyte growth
02/12/2009US20090042899 Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
02/12/2009US20090042879 Phthalazinone derivatives and pharmaceutical compositions comprising the same
02/12/2009US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders
02/12/2009US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control
02/12/2009US20090042834 Stabilized Glycosaminoglycan Preparations and Related Methods
02/12/2009US20090042771 Dietary lipids for improving skin and coat of pets
02/12/2009US20090042225 Method for selecting therapeutic agents for cancer treatment
02/12/2009US20090042221 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents; drug screening
02/12/2009US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection
02/12/2009US20090041875 Anti-wrinkle composition
02/12/2009US20090041874 Karaya Gum-Based Hydrophilic Gel System for Skin Care
02/12/2009US20090041866 Abnormal protein removing composition
02/12/2009US20090041859 Wound Treatment Drugs for External Use
02/12/2009US20090041856 Methods for promoting hair growth
02/12/2009US20090041846 Minocycline oral dosage forms for the treatment of acne
02/12/2009US20090041779 Aldosterone induced elastin production
02/12/2009US20090041735 CD34 Stem cell-related methods and compositions
02/12/2009US20090041726 Tumor therapy with high affinity laminin receptor-target vectors and combinations with chemotherapeutic agents
02/12/2009US20090041687 Use of opioid receptor antagonists
02/12/2009US20090041686 Topical acne vulgaris composition with a sunscreen
02/12/2009US20090041672 Drug for Treating or Diagnosing Vascular Lesion in the Skin or the Subcutaneous Soft Tissue Caused by Light Irradiation